GOVX (GeoVax Labs, Inc.) חוב לטווח קצר להון

GeoVax Labs, Inc. (GOVX) is a reputable developer of immune therapies for oncology and dangerous infections that has created effective gene data delivery systems. The US-based company relies on innovative viral vectors and government support. This debt-to-equity chart shows a value of 0.08. Meanwhile, the business is subject to significant binary risks due to its narrow specialization and dependence on external grants.

This ratio compares liabilities with a maturity of up to one year against equity, allowing for an assessment of the risk of cash flow gaps and the overall debt load. By analyzing the dynamics of the ratio between short-term liabilities and equity, investors determine the financial stability of GeoVax Labs, Inc. (GOVX) during periods of awaiting government grants and the completion of clinical trials for cancer and infection vaccines.